EUVIMEDEUVIMED entdecken
Crossref

A standardized carbon footprint assessment tool for injectable chemotherapy: Development and multicenter validation

Sophie Renet iD, Olivia Gautier iD, Caroline Galetto iD, Julien Duquesne iD, Martin Fenelon iD, Sebastien Taillemite iD, Meryam Jardin iD, Hail Aboudagga iD, Christelle Cousin iD, Pascale Brouard iD, Violaine Lepage iD, Chloé Gossery iD und 11 weitere

Journal of Oncology Pharmacy Practice · 20.11.2026

DOI: 10.1177/10781552261509980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 20.11.2026. Verfasst von Sophie Renet und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Groupe hospitalier Paris Saint-Joseph, Paris, France. Die Arbeit nennt 20 Literaturangaben. Gefördert von: The French National Academy of Pharmacy with the French Society for Oncology Pharmacy..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The environmental impact of oncology care is an increasing concern. Chemotherapy preparation and administration are resource-intensive processes, yet tools for assessing their carbon footprint (CF) remain scarce. This study aimed to develop and validate a tool for estimating the mean annual CF of chemotherapy cycles in practice.

Methods

A mixed-methods approach was conducted in three phases: tool development, multicenter testing, validation. A cradle-to-grave life cycle assessment (LCA) of three monoclonal antibodies (pembrolizumab, daratumumab, pertuzumab-trastuzumab) was performed in a French hospital. The assessment included pharmaceutical production, transport, preparation, administration, travel, and waste management. Results were used to identify emission drivers and develop an Excel ® -based tool with mandatory and optional modules. The tool was deployed in seven hospitals. Feasibility and transferability were assessed through comparison of CF estimates across centers. The tool outputs were compared with the reference monocentric LCA.

Results

All hospitals completed data collection and generated CF estimates using available data, without requiring LCA expertise. Mean emissions per chemotherapy session ranged from 12.63 to 31.27 kgCO 2 e. The administration phase was the largest contributor in all hospitals (16.08 ± 8.37 kgCO 2 e/session), largely driven by patient travel. Preparation-related emissions showed limited variability (3.68 ± 0.86 kgCO 2 e/session; coefficient of variation 18%). Validation showed good agreement with the reference LCA.

Conclusion

This study demonstrates that an adaptable LCA-based tool can be integrated into oncology practice to assess the CF of chemotherapy. By identifying emission hotspots, the tool supports decision-making toward more sustainable cancer care and contributes to the development of Green Oncology.

Schlagwörter

Stichwörter der Autor:innen

Carbon footprintchemotherapygreenhous gaslife-cycle assessmentoncologytool

Autor:innen und Institutionen

  • Department of Pharmacy, Groupe hospitalier Paris Saint-Joseph, Paris, France.
  • Department of Transformation, Innovation and Sustainable Development, Groupe hospitalier Paris Saint-Joseph, Paris, France.
  • Department of Pharmacy, CHU Nice - Hôpital Archet 2, Nice, France.
  • ECOVAMED, Paris, France.
  • Department of Pharmacy, CHU Caremeau Nîmes, Nîmes, France.
  • Department of Pharmacy, CHU Reims - Hôpital Robert Debré, Reims, France.

ORCID-Profile: Sophie Renet, Olivia Gautier, Caroline Galetto, Julien Duquesne, Martin Fenelon, Sebastien Taillemite, Meryam Jardin, Hail Aboudagga, Christelle Cousin, Pascale Brouard, Violaine Lepage, Chloé Gossery, Florian Slimano, André Rieutord, Laetitia Le, Emma Pinet, Marie-Alix Marchal, Marthe Rigal, Maxime Apparuit, Pascal Paubel, Julie Valette, Eric Raymond, Sandra Camps

Förderung

  • The French National Academy of Pharmacy with the French Society for Oncology Pharmacy.

Zitieren

APA

Renet, S., Gautier, O., Galetto, C., Duquesne, J., Fenelon, M., Taillemite, S., Jardin, M., Aboudagga, H., Cousin, C., Brouard, P., Lepage, V., Gossery, C., Slimano, F., Rieutord, A., Le, L., Pinet, E., Marchal, M. A., Rigal, M., Apparuit, M., …, & Camps, S. (2026). A standardized carbon footprint assessment tool for injectable chemotherapy: Development and multicenter validation. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261509980

Vancouver

Renet S, Gautier O, Galetto C, Duquesne J, Fenelon M, Taillemite S, et al. A standardized carbon footprint assessment tool for injectable chemotherapy: Development and multicenter validation. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261509980

BibTeX
@article{Renet2026,
  author = {Renet, Sophie and Gautier, Olivia and Galetto, Caroline and Duquesne, Julien and Fenelon, Martin and Taillemite, Sebastien and Jardin, Meryam and Aboudagga, Hail and Cousin, Christelle and Brouard, Pascale and Lepage, Violaine and Gossery, Chloé and Slimano, Florian and Rieutord, André and Le, Laetitia and Pinet, Emma and Marchal, Marie-Alix and Rigal, Marthe and Apparuit, Maxime and Paubel, Pascal and Valette, Julie and Raymond, Eric and Camps, Sandra},
  title = {A standardized carbon footprint assessment tool for injectable chemotherapy: Development and multicenter validation},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2026},
  doi = {10.1177/10781552261509980}
}
Kostenlos starten →